Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$23.9B
| $1.33B | 1.21% |
7,330,876
+299,876
| +4% | +$51.4M |
|
|
NVO
2
Novo Nordisk
NVO
$213B
| $1.12B | 1.02% |
42,689,832
+1,200,690
| +3% | +$29.5M |
|
3
Palo Alto Networks
PANW
$273B
| $1.09B | 0.99% |
26,904,900
+1,078,200
| +4% | +$40M |
|
4
Chipotle Mexican Grill
CMG
$41.3B
| $1.04B | 0.94% |
73,019,950
+10,997,000
| +18% | +$128M |
|
5
Vertex Pharmaceuticals
VRTX
$120B
| $934M | 0.85% |
5,078,717
+744,417
| +17% | +$137M |
|
6
PepsiCo
PEP
$185B
| $881M | 0.8% |
7,188,514
-91,736
| -1% | -$10.5M |
|
7
Humana
HUM
$47.7B
| $828M | 0.75% |
3,111,000
-396,800
| -11% | -$114M |
|
|
VMW
8
DELISTED
VMware, Inc
VMW
| $827M | 0.75% |
4,582,800
-450,668
| -9% | -$73.4M |
|
|
9
Starbucks
SBUX
$119B
| $823M | 0.75% |
11,073,986
+8,988,102
| +431% | +$618M |
|
10
Duke Energy
DUK
$99.7B
| $734M | 0.67% |
8,156,229
-53,550
| -0.7% | -$4.72M |
|
11
Domino's
DPZ
$10.6B
| $716M | 0.65% |
2,773,500
-312,000
| -10% | -$81.1M |
|
12
Amgen
AMGN
$198B
| $667M | 0.61% |
3,508,583
-70,017
| -2% | -$13.4M |
|
|
13
Meta Platforms (Facebook)
META
$1.59T
| $643M | 0.58% |
3,858,696
-2,150,666
| -36% | -$342M |
|
14
Align Technology
ALGN
$12.4B
| $643M | 0.58% |
2,260,000
-259,481
| -10% | -$61.9M |
|
15
GSK
GSK
$102B
| $596M | 0.54% |
11,418,080
+2,104,160
| +23% | +$105M |
|
16
Bristol-Myers Squibb
BMY
$124B
| $589M | 0.54% |
12,351,175
+5,404,300
| +78% | +$269M |
|
|
ABMD
17
DELISTED
Abiomed Inc
ABMD
| $589M | 0.54% |
2,060,923
+191,200
| +10% | +$63.5M |
|
18
Petrobras
PBR
$122B
| $553M | 0.5% |
34,718,800
+8,429,500
| +32% | +$134M |
|
19
BP
BP
$112B
| $532M | 0.48% |
12,371,407
+647,707
| +6% | +$26.5M |
|
20
Gilead Sciences
GILD
$162B
| $528M | 0.48% |
8,120,248
+2,730,700
| +51% | +$181M |
|
21
Molina Healthcare
MOH
$11.6B
| $525M | 0.48% |
3,695,205
-294,350
| -7% | -$39.8M |
|
22
Progressive
PGR
$119B
| $521M | 0.47% |
7,226,596
-604,800
| -8% | -$41.4M |
|
23
Ralph Lauren
RL
$23B
| $510M | 0.46% |
3,934,994
+348,794
| +10% | +$41.5M |
|
|
24
Crown Castle
CCI
$33.8B
| $500M | 0.45% |
3,903,300
-2,079,403
| -35% | -$244M |
|
|
MOMO
25
Hello Group
MOMO
$876M
| $494M | 0.45% |
12,927,803
+1,482,100
| +13% | +$47.4M |
|
Similar funds
Renaissance Technologies's Q1 2019 Portfolio in Review
As of Q1 2019, Renaissance Technologies held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Renaissance Technologies deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Renaissance Technologies's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Renaissance Technologies added most to Starbucks in Q1 2019, an estimated $618M increase.
- Renaissance Technologies's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Renaissance Technologies fully exited Apple in Q1 2019, selling an estimated $435M.
- Renaissance Technologies's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Renaissance Technologies opened 532 new positions and closed 465 in Q1 2019.
- Renaissance Technologies's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.